Trials / Completed
CompletedNCT00195520
Study Evaluating Totelle® in Menopausal Symptoms and Sexual Function
An Open Assessment of the Effect of Low-Dose Totelle® 1 mg on Menopausal Symptoms, Sexual Function and Quality of Life
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- Female
- Age
- 45 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the tolerability, bleeding patterns and acceptability of Totelle® 1mg administered to a population of Brazilian women in a continuous combined regime for hormone replacement therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Totelle® |
Timeline
- Start date
- 2004-12-01
- Completion
- 2006-12-01
- First posted
- 2005-09-19
- Last updated
- 2008-08-05
Locations
2 sites across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00195520. Inclusion in this directory is not an endorsement.